FDA Recalls: DOXOrubicin Hydrochloirde Liposome Injection; AVID Convenience Kit; MG217 Multi-Symptom Treatment Cream; Surgical Stapler Reload

Published: 05/14/2026

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

Recalls

Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL Due To Potential Presence of Glass Particles

Convenience Kit Recall: AVID Medical Removes Convenience Kits Containing Namic RA Syringes

Pharmacal Issues Nationwide Recall of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream Due to Microbial Contamination

Surgical Stapler Reload Recall: Intuitive Surgical Remove…

Sign Up for Free Trial